Development strategies for biomarker assays

被引：0
|
作者：
Shaffer, Catherine
机构：
来源：
Genetic Engineering and Biotechnology News | 2010年 / 30卷 / 05期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] PET Imaging TSPO in Major Depressive Disorder: Strategies for Biomarker Development
    Meyer, Jeffrey
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 2S - 2S
  • [22] Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases
    Kumar, Sundramurthy
    Karthikeyan, Narayanan
    Mishra, Sachin
    Padmanabhan, Parasuraman
    Radda, George
    Gulyas, Balazs
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2559 - 2578
  • [23] Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases
    Sundramurthy Kumar
    Narayanan Karthikeyan
    Sachin Mishra
    Parasuraman Padmanabhan
    George Radda
    Balázs Gulyás
    Molecular Neurobiology, 2019, 56 : 2559 - 2578
  • [24] Enrichment strategies in glycomics-based lung cancer biomarker development
    Ruhaak, L. Renee
    Uyen Thao Nguyen
    Stroble, Carol
    Taylor, Sandra L.
    Taguchi, Ayumu
    Hanash, Samir M.
    Lebrilla, Carlito B.
    Kim, Kyoungmi
    Miyamoto, Suzanne
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (9-10) : 664 - 676
  • [25] Proteomics and biochemical strategies for the development of breast cancer biomarker and treatment selection
    Kaliasniova, K. V.
    Bakakina, Y. S.
    Molchan, M. M.
    Kazlouskaya, N. A.
    Shukanova, N. A.
    Shapoval, E. V.
    Dubovskaya, L. V.
    Volotovski, I.
    FEBS JOURNAL, 2014, 281 : 594 - 594
  • [26] A Harmonized Biomarker Panel for Mood Trials: Validation of Assays, Identification of Most Sensitive Cytokine Assays, and Development of Functional Blood Culture Methods
    Triana-Baltzer, Gallen
    Schoene, Manja
    Patterson, Paula
    Salvadore, Giacomo
    Slemmon, Randy
    Furey, Maura
    Kolb, Hartmuth
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 182S - 183S
  • [27] From biomarker strategies to biomarker activities and back
    van Gool, Alain J.
    Henry, Brian
    Sprengers, Erik D.
    DRUG DISCOVERY TODAY, 2010, 15 (3-4) : 121 - 126
  • [28] Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment
    Azadeh, Mitra
    Good, Jeremy
    Gunsior, Michele
    Kulagina, Nadia
    Lu, Yanmei
    McNally, Jim
    Myler, Heather
    Ni, Yan G.
    Pelto, Ryan
    Quadrini, Karen J.
    Vrentas, Catherine
    Yang, Lin
    AAPS JOURNAL, 2024, 26 (05):
  • [29] Quality Assurance of Biomarker Assays in Clinical Trials
    Hall, J. A.
    Salgado, R.
    Peters, G. J.
    Martens, J. W. M.
    Sleijfer, S.
    Lacombe, D.
    Harbeck, N.
    Daidone, M. G.
    Sweep, F. C. G. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 137 - 137
  • [30] On the Statistical Accuracy of Biomarker Assays for HIV Incidence
    Brookmeyer, Ron
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (04) : 406 - 414
12345